Recombinant Brucella suis biovar 1 Protease HtpX homolog (HtpX) is a protein expressed by the bacterium Brucella suis biovar 1 . Brucella suis is a pathogenic bacterium known to cause brucellosis, an infectious disease that affects both animals and humans . Specifically, HtpX is a protease homolog, indicating its similarity to other HtpX proteases found in various organisms . Proteases are enzymes that catalyze the breakdown of proteins, playing critical roles in numerous cellular processes.
Recombinant HtpX is produced using genetic engineering techniques, where the gene encoding HtpX is inserted into a host organism (e.g., E. coli) to produce large quantities of the protein . This recombinant form of HtpX is valuable for research purposes, including:
ELISA assays: Recombinant HtpX can be used as an antigen in enzyme-linked immunosorbent assays (ELISA) to detect antibodies against Brucella suis in serum samples . This can aid in the diagnosis of brucellosis.
Structural and functional studies: Recombinant HtpX allows researchers to study the protein's structure, enzymatic activity, and interactions with other molecules.
Vaccine development: HtpX may be explored as a potential vaccine candidate or target for developing new therapies against Brucella infections.
Brucella suis can replicate inside mammalian cells, and their type IV secretion system is needed for survival inside cells and replication . Studying proteins like HtpX can reveal important details about the mechanisms that contribute to the bacterium's ability to cause disease. Further research on HtpX and other Brucella suis proteins may lead to the development of more effective diagnostic tools, treatments, and preventive measures against brucellosis.
KEGG: bms:BR1813
What is Brucella suis biovar 1 Protease HtpX homolog and what is its significance in bacterial physiology?
Protease HtpX homolog (htpX) is a membrane-bound zinc metalloprotease found in Brucella suis biovar 1 and other Brucella species. The protein consists of 325 amino acids and functions primarily in protein quality control and stress response mechanisms.
The protein belongs to the M48 peptidase family and is characterized by the presence of a HEXXH zinc-binding motif. In Brucella suis biovar 1 (strain 1330), HtpX is encoded by gene BS1330_I1807 (also designated as BR1813) . The protein functions as a membrane protease involved in degrading misfolded membrane proteins, particularly under stress conditions, which may contribute to bacterial survival during infection.
The amino acid sequence of Brucella suis HtpX shows significant homology to HtpX proteins in other Brucella species, with nearly identical sequences observed in B. abortus . This high conservation suggests an essential role in Brucella physiology.
What are the optimal expression systems for recombinant Brucella suis HtpX production?
For successful production of recombinant Brucella suis HtpX, E. coli-based expression systems have been most commonly employed. Based on available research protocols:
Expression vector: pET vectors (particularly pET-DEST42) have been used successfully for Brucella outer membrane proteins
Host strain: E. coli BL21 cells are preferred for IPTG-induced protein expression
Induction conditions: IPTG induction following transformation into expression hosts
Tags: N-terminal or C-terminal His-tags facilitate purification and detection
Methodology:
PCR amplification of the htpX gene from Brucella suis genomic DNA
Cloning into an entry vector and verification
Recombination into destination expression vector (pET-DEST42)
Transformation into E. coli BL21 cells
IPTG-induced expression
Verification by Western blot using anti-His antibodies
This approach has yielded recombinant proteins with >90% purity as determined by SDS-PAGE analysis .
What are the recommended storage and handling conditions for recombinant Brucella HtpX?
Optimal storage and handling conditions for recombinant Brucella HtpX protein:
| Parameter | Recommendation |
|---|---|
| Storage temperature | -20°C/-80°C for extended storage |
| Working aliquots | Store at 4°C for up to one week |
| Buffer composition | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 or Tris-based buffer with 50% glycerol |
| Recommended form | Lyophilized powder for long-term storage |
| Reconstitution | In deionized sterile water to 0.1-1.0 mg/mL |
| For long-term storage | Add 5-50% glycerol (final concentration) and aliquot |
| Important note | Avoid repeated freeze-thaw cycles |
Prior to opening, briefly centrifuge vials to bring contents to the bottom. After reconstitution, the addition of glycerol (typically to 50% final concentration) helps maintain protein stability during freeze-thaw cycles if necessary .
Has HtpX been evaluated as a component in subunit vaccine development against Brucellosis?
While HtpX specifically has not been extensively studied as a vaccine candidate, research on similar Brucella proteins provides a methodological framework:
Potential as a vaccine component:
As a conserved membrane protein, HtpX could represent a target for protective immunity
Recombinant HtpX could be included in multi-epitope vaccines
Methodological approach based on similar studies:
Epitope mapping to identify immunogenic regions
Design of multi-epitope constructs incorporating HtpX epitopes
Expression and purification of recombinant proteins
Immunization studies with appropriate adjuvants
Challenge studies to assess protection
A study on multi-epitope protein vaccines for Brucellosis demonstrated that "recombinant protein could be a subunit protein with sufficient efficiency in stimulating the humoral and cellular-mediated immune system against B. melitensis compared with common live attenuated B. melitensis Rev.1 vaccines." Similar approaches could be applied to assess HtpX as a vaccine component.
Experimental design would include:
T and B cell epitope prediction from HtpX sequence
Evaluation of immune responses (IFN-γ, IL-2, specific IgG)
Lymphocyte proliferation assays
Protection studies in animal models
How can recombinant HtpX be used in diagnostic applications for Brucellosis?
Recombinant Brucella proteins have significant potential for improving diagnostic tests. For HtpX:
Serological diagnostics:
ELISA development using purified recombinant HtpX
Western blot confirmation tests
Lateral flow assays for point-of-care testing
Methodological considerations:
Optimization of antigen coating concentration
Determination of serum dilution parameters
Establishment of cutoff values using known positive and negative samples
Evaluation of sensitivity and specificity
Cross-reactivity assessment with other bacterial infections
Validation approach:
Testing against serum panels from confirmed Brucella infections
Comparison with existing diagnostic methods
Field testing in endemic regions
Research has shown that some Brucella outer membrane proteins demonstrate "high binding activity with immunized rabbit antiserum" , suggesting potential diagnostic utility. For HtpX specifically, evaluation is needed to determine if it elicits a consistent and detectable antibody response during natural infection that could be leveraged for diagnostic purposes.
What is the relationship between HtpX and the BvrR/BvrS regulatory system in Brucella?
The BvrR/BvrS two-component system is essential for Brucella virulence, and its relationship with membrane proteins like HtpX is of research interest:
The BvrR/BvrS system:
Controls polycation peptide resistance, invasion, and intracellular survival
Regulates outer membrane structure and components
Controls expression of outer membrane proteins like Omp3a and Omp3b
Potential relationship with HtpX:
BvrR/BvrS may regulate htpX expression directly or indirectly
HtpX could process membrane proteins that are under BvrR/BvrS control
Both systems may function in coordinated response to environmental stresses
Research has shown that "BvrR/BvrS regulates the structure of outer membrane components important for homeostasis and virulence" . As a membrane protease involved in protein quality control, HtpX might play a role in maintaining membrane integrity under BvrR/BvrS regulation.
Experimental approaches to investigate this relationship could include:
Transcriptome analysis of bvrR/bvrS mutants to assess htpX expression
ChIP-seq to determine if BvrR directly binds the htpX promoter
Phenotypic analysis of double mutants (htpX and bvrR/bvrS components)